1) The document discusses the global threat of antibiotic resistance, noting it is a development and aid issue.
2) Key factors that have contributed to the rise of antibiotic resistance include overuse of antibiotics in agriculture, overprescription by doctors, lack of access to diagnostics in developing countries, and global travel and trade.
3) Addressing antibiotic resistance requires strengthening surveillance, rationalizing antibiotic use, securing access to effective antibiotics globally, developing new diagnostics and treatment guidelines, and reframing antibiotic resistance as a global health and development priority.
FLOW OF THE SEMINAR
1. Definition – antibiotic resistance, Multi-resistance, cross-resistance in antibiotics
2. Evolution of resistance
3. Impact of resistance
4. The scenario of resistance: Global, India
5. Factors causing resistance
6. Mechanisms of resistance: Intrinsic and Acquired
7. Acquired mechanism of resistance
8. Quorum sensing
9. Mechanism of resistance in commonly used antibiotics
10. Methods for determining the resistance
11. Strategies to contain resistance
12. Antibiotic stewardship
13. Role of Pharmacologist
14. Initiatives undertaken by India to control resistance
FLOW OF THE SEMINAR
1. Definition – antibiotic resistance, Multi-resistance, cross-resistance in antibiotics
2. Evolution of resistance
3. Impact of resistance
4. The scenario of resistance: Global, India
5. Factors causing resistance
6. Mechanisms of resistance: Intrinsic and Acquired
7. Acquired mechanism of resistance
8. Quorum sensing
9. Mechanism of resistance in commonly used antibiotics
10. Methods for determining the resistance
11. Strategies to contain resistance
12. Antibiotic stewardship
13. Role of Pharmacologist
14. Initiatives undertaken by India to control resistance
Sebastian Hielm: Antimicrobial resistance (AMR) and global health THL
Mr. Sebastian Hielm, Director of Food Safety, Ministry of Agriculture and Forestry, Finland, at One Health Security Conference, 14-15 Oct 2019, THL, Helsinki
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
Resistance to antibiotics is one of the main important facts that most nations are working on. Actually, in USA, it is considered as a health problem to solve. Why it happens? Here is a review to answer this.
Antimicrobial resistance is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals, and antifungals) from working against it.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Mechanism Antibiotic Resistance
Intrinsic (Natural)
Acquired
Chromosomal
Extra chromosomal
Intrinsic Resistance
Lack target : No cell wall; innately resistant to penicillin
2. Drug inactivation: Cephalosporinase in Klebsiella
3. Innate efflux pumps:
It is an active transport mechanism. It requires ATP.
Eg. E. coli, P. aeruginosa
Altered target sites
PBP alteration
Ribosomal target alteration
Decreased affinity by target modification
Beta-lactamase
Beta-lactamases are enzymes produced by bacteria that provide resistance to β-lactam antibiotics such as penicillins, cephamycins, and carbapenems
Major resistant Pathogen
1. PRSP- Penicillin resistant Streptococcus pneumoniae2. MRSA/ORSA- Methicillin-resistant Staphylococcus Aureus (Super bug)3. VRE -Vancomycin-Resistant Enterococci4. Carbapenem resistant pseudomonas aeruginosa5. Carbapenem resistant Carbapenem resistant 6. Extended spectrum beta-lactamase (ESBL)-producing bacteria
Please find the power point on Antimicrobial resistance. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Antimicrobial resistance as an emerging food-borne infectious diseaseJean Jacques Bernatas
Food safety is also about acquired antimicrobial resistance in big farms, and its spread in the environment. Be a smart consumer, a smart producer, and a smart patient to contributing to get antimicrobial resistance under control.
Sebastian Hielm: Antimicrobial resistance (AMR) and global health THL
Mr. Sebastian Hielm, Director of Food Safety, Ministry of Agriculture and Forestry, Finland, at One Health Security Conference, 14-15 Oct 2019, THL, Helsinki
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
Resistance to antibiotics is one of the main important facts that most nations are working on. Actually, in USA, it is considered as a health problem to solve. Why it happens? Here is a review to answer this.
Antimicrobial resistance is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals, and antifungals) from working against it.
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Mechanism Antibiotic Resistance
Intrinsic (Natural)
Acquired
Chromosomal
Extra chromosomal
Intrinsic Resistance
Lack target : No cell wall; innately resistant to penicillin
2. Drug inactivation: Cephalosporinase in Klebsiella
3. Innate efflux pumps:
It is an active transport mechanism. It requires ATP.
Eg. E. coli, P. aeruginosa
Altered target sites
PBP alteration
Ribosomal target alteration
Decreased affinity by target modification
Beta-lactamase
Beta-lactamases are enzymes produced by bacteria that provide resistance to β-lactam antibiotics such as penicillins, cephamycins, and carbapenems
Major resistant Pathogen
1. PRSP- Penicillin resistant Streptococcus pneumoniae2. MRSA/ORSA- Methicillin-resistant Staphylococcus Aureus (Super bug)3. VRE -Vancomycin-Resistant Enterococci4. Carbapenem resistant pseudomonas aeruginosa5. Carbapenem resistant Carbapenem resistant 6. Extended spectrum beta-lactamase (ESBL)-producing bacteria
Please find the power point on Antimicrobial resistance. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Antimicrobial resistance as an emerging food-borne infectious diseaseJean Jacques Bernatas
Food safety is also about acquired antimicrobial resistance in big farms, and its spread in the environment. Be a smart consumer, a smart producer, and a smart patient to contributing to get antimicrobial resistance under control.
Literature Survey Antibiotic ResistanceTuhin Samanta
Anti-toxin obstruction happens when microscopic organisms change in light of the utilization of these medications. Microscopic organisms, not people or creatures, become anti-toxin safe. These microorganisms may contaminate people and creatures, and the diseases they cause are more diligently to treat than those brought about by non-safe microscopic organisms.
The use of antimicrobial in humans and animals, the consequences of this use, the political and economic barriers to improve prudent use and possible solutions for this problem.
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...Johns Hopkins University
On 12/2/09 on Capitol Hill, leading experts in economics, public health and public policy and Rep. Louise Slaughter (D-NY), a leading voice on antibiotic resistance, discussed the impact of resistant infections on the U.S. healthcare system and the need to phase out inappropriate use of antibiotics as growth promoters in the production of food animals. The Johns Hopkins Center for a Livable Future (CLF) hosted the event with Rep. Slaughter. This is a complication of the panelists' presentations.
Identification of antibiotic resistance genes in Klebsiella pneumoniae isolat...QIAGEN
Antibiotic resistant strains of pathogenic bacteria are a growing worldwide health problem. To effectively combat the spread of difficult-to-treat bacterial infections, rapid surveillance methods for detection of antibiotic resistance genes is required to monitor both bacterial isolates and metagenomic samples. Additionally, identification of potential new sources for different antibiotic resistance genes is critical. Both of these goals require tools that can be used for profiling of antibiotic resistance genes from various types of samples. Real-time PCR has proven to be effective for the detection of antibiotic resistance genes. Using PCR array technology, simultaneous detection of 87 prevalent and important antibiotic resistance genes is possible and should prove to be an effective method for antibiotic resistance monitoring. This allows for a more comprehensive profiling of antibiotic resistance genes than is possible using individual PCR assays.
Dr. Benjamin Park - Antimicrobial Resistance in Humans and the Global Health ...John Blue
Antimicrobial Resistance in Humans and the Global Health Security Agenda - Dr. Benjamin Park, Senior Advisor for International Healthcare Quality, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), from the 2015 NIAA Antibiotic Symposium - Stewardship: From Metrics to Management, November 3-5, 2015, Atlanta, Georgia, USA.
More presentations at http://swinecast.com/2015-niaa-symposium-antibiotics-stewardship-from-metrics-to-management
Dr. James Hughes - Combating Antimicrobial Resistance: The Way ForwardJohn Blue
Combating Antimicrobial Resistance: The Way Forward - Dr. James Hughes, Professor of Medicine and Public Health with Joint Appointments in the School of Medicine and the Rollins School of Public Health at Emory University, from the 2014 NIAA Symposium on Antibiotics Use and Resistance: Moving Forward Through Shared Stewardship, November 12-14, 2014, Atlanta, Georgia, USA.
More presentations at http://www.swinecast.com/2014-niaa-antibiotics-moving-forward-through-shared-stewardship
World Veterinary Day 2017 Presentation made at the College of Veterinary and Animal Science, Navania, Vallabhnagar, Udaipur by DR. BALWANT MESHRAM on the topic 'WVD: Past and the Present'
Awareness Session On Antimicrobial resistance “Antimicrobials: Spread Awaren...Nimra zaman
The World Antimicrobial Awareness Week (WAAW) was introduced by the World Health Organization (WHO) to increase global awareness of antimicrobial resistance.
The WAAW takes place every year from 18-24th of November.
The theme of World Antimicrobial Awareness Week (WAAW) 2021 is ‘Spread Awareness, Stop Resistance’.
During this week best practices are shared among the general public, health workers and policy makers to show the importance of stopping the further emergence and spread of antibiotic resistance.
Dr. Ruth Lynfield - One Health Antibiotic Stewardship: A Collaborative ApproachJohn Blue
One Health Antibiotic Stewardship: A Collaborative Approach - Dr. Ruth Lynfield, State Epidemiologist and Medical Director, Minnesota Department of Health, from the 2017 NIAA Antibiotic Symposium - Antibiotic Stewardship: Collaborative Strategy for Animal Agriculture and Human Health, October 31 - November 2, 2017, Herndon, Virginia, USA.
More presentations at http://www.swinecast.com/2017-niaa-antibiotic-symposium-antibiotic-stewardship
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Antibiotic Resistance as a development and aid issue
1. The Global Threat of Antibiotic Resistance:
a development and aid issue
MT Bejarano. MD,PhD
Sida. Unit for Research Cooperation
2. Antimicrobial resistance (AMR)
Antiviral
agents
e.g drugs for
HIV, FLU,
Herpes
Antiparasitic
agents
e.g drugs for
malaria,
leishmaniasis
Antibacterial
agents
=Antibiotics
e.g. drugs for TB
and other
bacterial
infections
Antifungal
agents
e.g drugs for
Candidiasis
3. Bacteria and us
• Babies: sterile in uterus
• colonized with bacteria during the 1st
months
• Adults have 2 Kg bacteria in body
• 10 times more bacteria than human cells
• >1,000 different species of bacteria in
intestine
4. What is Antibiotic resistance?
The ability of bacteria to avoid the harmful
effects of an antibiotic
6. ANTIBIOTICS
• Underpin health care
• A non-renewable resource
• Most falsified medicines (28% global falsified
medicines)
7. Antibiotic Resistance is a Global Threat
“If current trends
continue unabated, the
future is easy to predict.
Some experts say we are
moving back to the pre-
antibiotic era. No. This
will be a post-antibiotic
era.”
Dr M Chan. DG WHO; March 2012
8. How did we end up here?
Agri/Aqua/culture- veterinary
Prescription, patient pressure, OTC sales
Water, Soil, Waste
Travel, migration, trade
Patient movement. hosp. cleanliness
Profit, scientific, regulations
Humans
Animals
Medicine
Environment
Globalization
Medical Tourism
R&D failure
ABR
Adapted from The Telegraph, 2014
11. Primary health care, Paediatric care and
nutrition
• Lack of diagnostic tools in
PHC and hospital settings
- Differential diagnosis of
fever (bacterial vs viral)
- Access to culture and drug
sensitivity tests
- Syndromic approach
=
Systematic and irrational
use of antibiotics
12. China: Intravenous antibiotics
for common colds
Yearly antibiotic use per capita
Sweden :7 grams China :138 grams
Prescription, patient pressure, OTC sales
13.
14. Larsson DGJ, de Pedro C, Paxeus N. 2007. Effluent from
drug manufactures contains extremely high levels of
pharmaceuticals. J Haz Mat. 148 (3), 751-755
Water, Soil, Waste
15. 24 % of Swedish tourists carry multiresistant (ESBL E.coli)
in the gut after coming home from holiday outside the
Nordic countres
Resistant bacteria travel with us at an
unprecedented speed
Tängden et al Antimicrob. Agents Chemother. doi:10.1128/AAC.00220-10
Travel, migration, trade
17. Children with Acute Lower Respiratory Infections in
Africa, Asia, Latin America:
404 Million antibiotic prescriptions could be
avoided with a rapid test for bacterial infections
.
Lim et al. Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature,
2006.
NO DIAGNOSTIC TOOLS
18. GBD 2010 study. The Lancet 2012.
WHO
And 1/10 of all global deaths
Bacterial infections account for
≈ 1/3 of all child deaths globally
630.000 children died of pneumonia in 2013
19. Sepsis in newborns in five countries in South Asia
(India, Pakistan, Afghanistan, Nepal, Bangladesh)
One child dies every five minutes because the
antibiotics given are not effective due to
bacterial resistance
Zulfiqar Bhutta presentation at ReAct
conference Sep. 2010
20.
21. “It is anticipated to be only a
matter of time before
gonococci with full
resistance to the third-
generation extended
spectrum cephalosporins
emerge and spread
internationally.
Consequently, gonorrhoea
may become untreatable
unless new drugs become
available.”
WHO AMR surveillance report 2014
23. Adapted from Källander 2005
The inequitable and non-sustainable
use of a scarce global resource
24. Across developing countries only 1/3 children with suspected
pneumonia receive ABs
Pneumonia and diarrhoea: Tackling the deadliest diseases for the world’s poorest
children. New York, NY: United Nations Children’s Fund (UNICEF): June 2012.
29. Why the global complacency ?
• ABR has no disease or economic face
• Scarce data on global antibiotic use
global resistance levels and trends
• Inadequate data on the global health and
economic burden
• The global self-deception: There will always be new
antibiotics
30.
31.
32. Knowledge gaps
• Burden of ABR
• Global surveillance, standarization
• Health & economic burden
• Assess economic impact in health system
and society
33. Minimize morbidity and mortality from bacterial
infection
implementation of interventions to reduce spread of bacterial infections e.g.
clean water , basic hygienic rules soap and alcoholic hand rub
34. Secure access to effective and
affordable antibiotics
• Make access to effective Abs
an aid issue ≈ to TB, malaria,
HIV.
• address local realities of
difficult access, poor quality of
medicines
• New Abs part of essential
medicines, subsidized by UHC
schemes
35. Support countries in developing national
coordinated policies and:
• Strengthen surveillance capacity
• Support regulatory authorities
• Support & institutionalize data collection of AB prescribing,
dispensing and sales
• Educational and regulatory interventions in the health care
system for rational prescribing of antibiotics
• Major changes in knowledge, understanding and
perception of antibiotics to reduce demand.
36. Reframing the issue
• Health and global security
• Access to effective antibiotics
• Antibiotics are lifesaving global public good not a
commercial commodity
• Essential for any health system
• Universal health coverage
• Sustainable development
• Ecology/environment/Onehealth
39. Antibiotic Resistance
Caused by human activity and by over- consumption of a global
resource
A failure of public policy & global governance, health systems,
research prioritization and the current market system
It is a collective responsibility by governments, supranational
organizations and individuals to take action
Nasa 1969: Earthrise over the moon from Apollo II